Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.9981
-0.0019 (-0.19%)
At close: May 11, 2026, 4:00 PM EDT
0.9825
-0.0156 (-1.56%)
After-hours: May 11, 2026, 7:59 PM EDT
Tenaya Therapeutics Employees
Tenaya Therapeutics had 70 employees as of December 31, 2025. The number of employees decreased by 27 or -27.84% compared to the previous year.
Employees
70
Change (1Y)
-27
Growth (1Y)
-27.84%
Revenue / Employee
$3,214
Profits / Employee
-$1,185,786
Market Cap
216.59M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 70 | -27 | -27.84% |
| Dec 31, 2024 | 97 | -43 | -30.71% |
| Dec 31, 2023 | 140 | -1 | -0.71% |
| Dec 31, 2022 | 141 | 35 | 33.02% |
| Sep 30, 2022 | 140 | 40 | 40.00% |
| Jun 30, 2022 | 135 | 50 | 58.82% |
| Mar 31, 2022 | 125 | 50 | 66.67% |
| Dec 31, 2021 | 106 | 31 | 41.33% |
| Sep 30, 2021 | 100 | 25 | 33.33% |
| Jun 30, 2021 | 85 | - | - |
| Mar 31, 2021 | 75 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tonix Pharmaceuticals Holding | 142 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Nkarta | 108 |
| Alector | 103 |
| Camp4 Therapeutics | 48 |
| Sol-Gel Technologies | 28 |
| Unicycive Therapeutics | 22 |
TNYA News
- 5 days ago - Tenaya Therapeutics reports Q1 EPS (9c), consensus (9c) - TheFly
- 5 days ago - Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 14 days ago - Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026 - GlobeNewsWire
- 24 days ago - Tenaya Therapeutics Duchenne muscular dystrophy treatment granted orphan status - TheFly
- 2 months ago - Tenaya Therapeutics reports Q4 EPS (12c), consensus (12c) - TheFly
- 2 months ago - Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Tenaya Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Tenaya Therapeutics presents preclinical data evaluating TN-301 - TheFly